revealed that over 80% of ALCL cases had downregulation of CD58, with these cases also demonstrating ALK deficiency, whereas 75% of DUSP-22 positive individuals displayed positive CD58 expression (62). The gene discussed is ALK; the disease is anaplastic large cell lymphoma.